Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Gyre Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −11 vs. Q1 2023
- Shares held
- 2.27M
- −1.10M (−32.7%) vs. Q1 2023
- Total value
- $796.3K
- +$88.7K (+12.5%) vs. Q1 2023
- New holders
- 3
- 4 more added
- Sold out
- 14
- 9 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $57.1M |
| Q1 2026 | 56 | $23.8M |
| Q4 2025 | 44 | $23.6M |
| Q3 2025 | 48 | $23.1M |
| Q2 2025 | 48 | $25.1M |
| Q1 2025 | 46 | $20.1M |
| Q4 2024 | 41 | $21.6M |
| Q3 2024 | 37 | $20.2M |
| Q2 2024 | 30 | $15.0M |
| Q1 2024 | 21 | $14.3M |
| Q4 2023 | 16 | $15.6M |
| Q3 2023 | 32 | $1.04M |
| Q2 2023 | 29 | $796.3K |
| Q1 2023 | 40 | $707.6K |
| Q4 2022 | 35 | $2.63M |
| Q3 2022 | 35 | $3.90M |
| Q2 2022 | 41 | $14.2M |
| Q1 2022 | 43 | $6.39M |
| Q4 2021 | 51 | $13.7M |
| Q3 2021 | 66 | $75.7M |
| Q2 2021 | 69 | $87.7M |
| Q1 2021 | 89 | $113.0M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Gyre Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 774,386 | $272.0K | 0.00% | −101,500−11.6% | Reduced |
| Geode Capital Management, LLC | 270,033 | $94.9K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 153,657 | $54.0K | 0.00% | −16,247−9.6% | Reduced |
| Acadian Asset Management LLC | 144,028 | $50.0K | 0.00% | −115,439−44.5% | Reduced |
| Kynam Capital Management, LP | 89,886 | $31.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 86,412 | $30.4K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 76,098 | $26.8K | 0.00% | +37,694+98.2% | Added |
| State Street Corp | 72,599 | $25.5K | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 67,800 | $23.8K | 0.00% | −92,630−57.7% | Reduced |
| Johnson & Johnson | 66,951 | $23.5K | 0.01% | 00.0% | Unchanged |
| Barclays PLC | 60,204 | $21.2K | 0.00% | 00.0% | Unchanged |
| Parallax Volatility Advisers, L.P. | 59,353 | $20.9K | 0.00% | −19,259−24.5% | Reduced |
| Susquehanna International Group, LLP | 55,043 | $19.4K | 0.00% | −3,204−5.5% | Reduced |
| Group One Trading, L.P. | 48,878 | $17.2K | 0.00% | −15,921−24.6% | Reduced |
| Bank of America Corp | 48,468 | $17.0K | 0.00% | +16,355+50.9% | Added |
| Virtu Financial LLC | 48,633 | $17.0K | 0.00% | +48,633 | New |
| Colorado Capital Management, Inc. | 34,165 | $12.0K | 0.01% | 00.0% | Unchanged |
| HSBC Holdings PLC | 32,528 | $11.5K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 25,983 | $9.15K | 0.00% | +25,983 | New |
| Keebeck Wealth Management, LLC | 20,000 | $7.03K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 14,683 | $5.16K | 0.00% | +14,683 | New |
| Raymond James & Associates | 12,900 | $4.54K | 0.00% | −50,000−79.5% | Reduced |
| Cutler Group LP | 5,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,285 | $452 | 0.00% | −92−6.7% | Reduced |
| BNP Paribas Arbitrage, SA | 277 | $97 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 215 | $76 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 190 | $67 | 0.00% | +7+3.8% | Added |
| JPMorgan Chase & Co | 52 | $18 | 0.00% | +1+2.0% | Added |
| GWM Advisors LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −272,313−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −200,638−100.0% | Sold out |
| Buckingham Strategic Wealth, LLC | 0 | $0 | 0.00% | −43,100−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −81,851−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −50,750−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −50,314−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −44,435−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −21,423−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −15,855−100.0% | Sold out |
| Arete Wealth Advisors, LLC | 0 | $0 | 0.00% | −10,345−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −10−100.0% | Sold out |